← Open Payments lookup

AMY RIORDAN: Open Payments

NPI 1497121552 · MAYS LANDING, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$672 in 45 payments from 13 companies in 2025. Trend: 2023 $201 · 2024 $485 · 2025 $672

Food & beverage: $672
CompanyPaymentsAmount
ABBVIE INC.12$195
Novo Nordisk Inc14$149
Amgen Inc.4$72
Esperion Therapeutics, Inc.3$44
Phadia US Inc.2$40
PFIZER INC.2$37
Lilly USA, LLC2$31
SANOFI-AVENTIS U.S. LLC1$21
AstraZeneca Pharmaceuticals LP1$18
Sumitomo Pharma America, Inc.1$18

Products named: UBRELVY, VRAYLAR, Ozempic, Rybelsus, QULIPTA, NEXLETOL, Wegovy, ImmunoCAP.

Industry payments across NJ — which companies pay providers there.